NDLR 2020 Conference POSTPONED
Due to increasing travel restrictions related to COVID-19, the NDLR Executive in consultation with the Leukaemia Foundation of Australia has decided to postpone the NDLR 2020 Conference. The Conference will now take place at the Brisbane Convention and Exhibition Centre from Tuesday 9 March – Thursday 11 March 2021.
We regret the inconvenience caused, but feel this is necessary to protect the health and safety of attendees and their associates.
Please keep an eye out on the website with further instructions regarding registrations, flights, accommodation, and rescheduled 2021 meeting dates.
We wish to thank everyone involved for your support of NDLR, and your patience during this time.
Matthew McCormack & Ross Dickins (co-conveners)
The Scientific and Organising Committees invite you to participate in the 8th New Directions in Leukaemia Research (NDLR) meeting to be held at the Brisbane Convention and Exhibition Centre in Queensland, Australia, from Monday 23 March to Wednesday 25 March, 2020.
The goal of the NDLR conferences is to bring together scientists and clinicians to discuss emerging paradigms and breakthroughs at the forefront of leukaemia research and treatment, from the molecular basis of leukaemia to new therapies emerging in the clinic.
As one of the premier international leukaemia conferences, NDLR 2020 will again bring together early-career investigators and senior scientists. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, allowing new collaborations to be forged.
Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR conferences offer a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.
We look forward to seeing you at NDLR 2020.
Associate Professors Matthew McCormack & Ross Dickins (co-chairs)
NDLR 2018 Delegates